INMED PHARMACEUTICALS INC. Payments for (Proceeds from) Other Investing Activities
INMED PHARMACEUTICALS INC. (INM) reported Payments for (Proceeds from) Other Investing Activities of $1.79 thousand for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2023-09-29
- INMED PHARMACEUTICALS INC. payments for (proceeds from) other investing activities for the quarter ending 2023-06-30 was -$126.41K.
- INMED PHARMACEUTICALS INC. payments for (proceeds from) other investing activities for fiscal 2023 was $1.79K.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|
| 2023-06-30 | -$126.41K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-29 | $1.79K 10-K · filed 2023-09-29 | |
| 2023-03-31 | $128.20K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |